Rare hormone disorder leaves young adults vulnerable to heart disease and diabetes

A new study reveals that people treated for congenital adrenal hyperplasia face elevated risks of heart disease, stroke, and metabolic disorders in adulthood—even when hormone treatment appears well-controlled. The finding suggests current treatment protocols may need revision to prevent costly long-term complications in a growing patient population.

Originaltitel: Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia